You are here
Home > Health > Praava Health receives donation from One Million Masks

Praava Health receives donation from One Million Masks

Praava Health has recently received a donation from One Million Masks – a charitable organization based in New York City in the United States – to support its work in the global fight against COVID, a press release said.

The donation is being made to offset the cost of sequencing COVID samples – a project that Praava is currently working with the research foundation Child Health Research Foundation (CHRF) to identify which variants are captured in the samples being processed at Praava Health. Data from Praava Health’s samples are contributing to GISAID, a global, open-access repository of SARS-CoV-2 genome sequences. The amount of the donation is not being made public.

One Million Masks is a grassroots initiative started by NewsCred CoFounder & CEO and CEO at Welcome Software Shafqat Islam. The team at One Million Masks is working with a goal to get one million masks to healthcare workers on the front lines in New York and beyond.

“Since the beginning of the pandemic, Praava has processed more than 150,000 COVID tests, approximately 3% of the total tests done in Bangladesh to date. We are so grateful to One Million Masks for their generous contribution to help us to accelerate our work in sequencing some of our COVID samples to contribute to the local and global understanding of the COVID-19 virus,” said Sylvana Q. Sinha, Praava Health’s Founder, Chair, & CEO.

“1 Million masks initially started as an initiative to help New Yorkers in need. But we quickly realized that there are people all over the world who we could help. And given our team and roots in Bangladesh, we’re thrilled to be able to partner with Praava Health. They’re doing incredible work on the ground, and we felt it was the fastest way to make an impact in Bangladesh,” said Shafqat Islam, CoFounder & CEO of NewsCred

Facebook Notice for EU! You need to login to view and post FB Comments!

Similar Articles

Leave a Reply

Top